Trialbee and TriNetX Partner
Trialbee, a technology provider in patient matching and engagement, is partnering with TriNetX, a global real-world health research network comprised of >170M patients across 23 countries to support data-driven digital solutions.
“This partnership will significantly widen Trialbee’s service offerings to drive patient recruitment and retention,” said Lollo Eriksson, CEO of Trialbee. “This is a great opportunity to leverage both organizations capabilities to develop new services in order to optimize clinical trials to empower patients with clinical trials as a care option. TriNetX is the market leader in leveraging real world data for the applications of clinical trial design, feasibility and site selection, and we look forward to embarking on this journey together.”
Trialbee develops innovative software to reduce clinical trial recruitment timelines and enhance the patient engagement experience, and TriNetX optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE). TriNetX’s access to patients through its global healthcare organizations (HCO) partners as well as through publicly available sources, and Trialbee’s expertise in patient recruitment and digital outreach represent a multi-pronged approach to identify, engage, and drive patients to clinical trials, improving efficiency and time-to-market.
With TriNetX’s real-time access to a large data repository, patient populations, and network of HCOs, and Trialbee’s seamless patient recruitment experience, the two companies will harness the power of RWE and real-time analytics to support customers with their end goals of protocol design, site selection, patient recruitment and retention.
“Our collaboration with Trialbee further enhances our healthcare organizations’ capabilities to streamline patient identification and recruitment. We see this partnership as a complementary effort to our digital developments around protocol design, site identification and access to patients.” said Maulik Mehta, Sr. VP Corporate Development. “Together, TriNetX and Trialbee will further enable clinical research as an alternative care option to patients.”
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
